Professor of Medicine, Harvard Medical School. Co-Director, Center for Weight Management and Wellness, Brigham and Women’s Hospital
Dr. Apovian is Co-Director of the Center for Weight Management and Wellness (CWMW) in the Division of Endocrinology, Diabetes, and Hypertension at Brigham and Women’s Hospital and a member of the faculty at Harvard Medical School. For over thirty years, Dr. Apovian has held a position at the forefront of the obesity and nutrition fields. One of the world’s premier weight management experts, she has distinguished herself as a leading researcher, healthcare provider, teacher, and New York Times bestselling author.
In collaboration with the Division of Gastroenterology, Hepatology and Endoscopy and the Division of Gastrointestinal and General Surgery, the CWMW will offer comprehensive, multidisciplinary care for patients seeking weight loss. Under Dr. Apovian’s direction, the Endocrinology arm of the Center will specialize in the assessment and treatment of obesity and its comorbidities. Nationally, she is one of the founding creators of the American Board of Obesity Medicine which provides certification and recognition for physicians who have specialized knowledge and training in the practice of obesity medicine.
Her current research interests are weight change and its effects on adipose tissue metabolism and inflammation, obesity and cardiovascular disease, resolution of type 2 diabetes and cardiovascular disease in the bariatric surgery population, disparities in the treatment of obesity in underserved populations, and novel pharmacotherapeutic agents for the treatment of obesity. She is also an expert in sampling subcutaneous adipose tissue and muscle tissue in humans and has been studying the relationship between adipose tissue inflammation and obesity for over 15 years.
Dr. Apovian has published over ten books and over 200 peer-reviewed original research and review articles on obesity and nutrition. Dr. Apovian was a member of the expert panel for updating the 2013 AHA/ACC/TOSClinical Guidelines for the Management of Overweight and Obesity in Adults, published in theCirculationandObesityjournals and was the Chair of the Endocrine Society Guidelines for Medical Treatment of Obesity published in theJournal of Endocrinology and Metabolismin 2015. She is a former Nutrition Consultant for the National Aeronautics and Space Administration (NASA). Dr. Apovian has given over 200 invited lectures nationally and internationally and served as President of The Obesity Society in 2017-2018. She is also currently the Co-Director for the NIH-funded Boston Nutrition and Obesity Research Center.
Dr. Apovian has participated on advisory boards for Abbott Nutrition, Allergan, Inc., Altimmune, Inc., Cowen and Company, LLC, Curavit Clinical Research,EnteroMedics, Gelesis, Srl., Jazz Pharmaceuticals, Inc., L-Nutra, Inc., NeuroBo Pharmaceuticals, Inc., Novo Nordisk, Inc., Pain Script Corporation, Real Appeal, Riverview School, Rhythm Pharmaceuticals, Roman Health Ventures, Inc., Scientific Intake Ltd. Co., Tivity Health, Inc., Xeno Biosciences andZafgen Inc.Dr. Apovian has received research funding from NIH, PCORI, GI Dynamics Inc., and Novo Nordisk.
Sanford I. Weill Professor of Metabolic Research, Weill Cornell Medical College. Director of the Comprehensive Weight Control Center, New York Presbyterian/Weill Cornell Medical Center New York Presbyterian/Weill Cornell Medical Center
Dr. Aronne is a leading authority on obesity and its treatment. He is the Sanford I. Weill Professor of Metabolic Research at Weill-Cornell Medical College and directs the Center for Weight Management and Metabolic Clinical Research, a state-of-the-art, multidisciplinary obesity research and treatment program. He has an adjunct appointment at Columbia University College of Physicians and Surgeons. Dr. Aronne is Founder and CEO ofBMIQ,一个是由他的体重控制计划alth care providers to their patients during office visits. Dr. Aronne graduated Phi Beta Kappa from Trinity College with a BS in biochemistry and from Johns Hopkins University School of Medicine. He completed his internship and residency at Albert Einstein College of Medicine and the Bronx Municipal Hospital Center, followed by a Henry J. Kaiser Family Foundation Fellowship at New York Hospital-Cornell Medical Center. He is a member of the Alpha Omega Alpha Medical Honor Society. Dr. Aronne is former president of the Obesity Society and a Fellow of the American College of Physicians. Vice-chairman of the board of the American Board of Obesity Medicine, he has authored more than 60 papers and book chapters on obesity and edited the National Institutes of HealthPractical Guide to the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. He served as a consultant to the VA Weight Management/Physical Activity Executive Council in the development of theMOVEprogram, the nation’s largest medically based weight control program. Dr. Aronne has won several awards for medical teaching, including the Davidoff Prize from Albert Einstein College of Medicine and the Elliot Hochstein Award from Cornell University.
Dr. Aronne reports receiving consulting fees from/and serving on advisory boards for Allurion, Altimmune, Atria, Gelesis, Jamieson Wellness, Janssen Pharmaceuticals, Jazz Pharmaceuticals, Novo Nordisk, Pfizer, Optum, Eli Lilly, Senda Biosciences and Versanis; receiving research funding from Allurion, Astra Zeneca, Gelesis, Janssen Pharmaceuticals, Novo Nordisk and Eli Lilly; having equity interests in Allurion, ERX Pharmaceuticals, Gelesis, Intellihealth, Jamieson Wellness and Myos Corp; and serving on a board of directors for ERX Pharmaceuticals, Intellihealth and Jamieson Wellness.
Board of Directors’ Member: ERX Pharmaceuticals, Intellihealth Corp, Jamieson Wellness. Equity Interests: Allurion, ERX Pharmaceuticals, Gelesis, Intellihealth, Jamieson Wellness, Myos Corp. Research Funding: Allurion, AstraZeneca, Gelesis, Janssen Pharmaceuticals, Novo Nordisk, Eli Lilly. Consultant/Advisory Board Member: Allurion, Altimmune, Atria, Gelesis, Jamieson Wellness, Janssen Pharmaceuticals, Jazz Pharmaceuticals, Novo Nordisk, Pfizer, Optum, Eli Lilly, Senda Biosciences, Versanis
Assistant Professor of Medicine Weill Cornell Medicine. Comprehensive Weight Control Center, Division of Endocrinology, Diabetes, and Metabolism.
New York, NY
Dr. Barenbaum is an Assistant Professor of Clinical Medicine at Weill Cornell Medical College and an Assistant Attending Physician at NewYork-Presbyterian Hospital. Dr. Barenbaum specializes in the care of patients with obesity and weight-related medical complications.Dr. Barenbaum sees patients at the Comprehensive Weight Control Center, and also with the GI Metabolic and Bariatric Surgery program, where she serves as the Obesity Medicine Director.
Dr. Barenbaum received her B.A. from Yale University, where she won two NCAA Division I national championships in squash and received the College Squash Assocation's scholar athlete award. She received her M.D. from Drexel University College of Medicine, where she won the Samuel M. Levit Award for Clinical Excellence & Bridging the Gaps Clinical Scholar. Dr. Barenbaum completed both her Residency & Obesity Medicine Fellowship at Weill Cornell Medicine/NewYork-Presbyterian Hospital.
No financial relationships to disclose
Source:Content for this module was reproduced with permission from: Apovian CM, Aronne L, Barenbaum SR.Clinical Management of Obesity. 2nded. Professional Communications Inc. 2022. All rights reserved.